Market authorization holder - 51461000087108
View Market authorization holder subset
Concept details
Moderna Biopharma Canada Corporation
Pan-Canadian SNOMED CT terminology
- Concept code
- 51461000087108
- Concept status
- active
- Version
- 20240531
- Display name
- English: Moderna Biopharma Canada Corporation
- French: Moderna Biopharma Canada Corporation
- Fully specified name
- Moderna Biopharma Canada Corporation (supplier)
Linked concepts
Linked tradename concept(s)
- COVID-19 SPIKEVAX (original strain) 0.10 mg/mL mRNA Mod
- COVID-19 SPIKEVAX (original strain) 0.20 mg/mL mRNA Mod
- COVID-19 SPIKEVAX 0.10 mg/mL mRNA Mod
- COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.1) 0.10 mg/mL mRNA Mod
- COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) 0.10 mg/mL mRNA Mod
- COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) pediatric 10 mcg/0.2mL mRNA Mod
- COVID-19 SPIKEVAX XBB.1.5 0.10 mg/mL mRNA Mod
- RSV mRESVIA mRNA Mod
National Vaccine Catalogue database details
- Last updated
- 2025-02-06
Concept history
This concept replaces
| Concept code | Display name |
|---|---|
| No data is available | |
Notice
Some information normally contained in the National Vaccine Catalogue may be unavailable due to ongoing mapping updates or because the source data did not provide the information, and in some cases, the information field is blank as it may not be applicable in the given context. The information contained in the National Vaccine Catalogue may also be subject to change following data reconciliation.
Disclaimer
The use of the standard SNOMED CT terminology and codes is subject to your annual acceptance of both the SNOMED CT® Affiliate License Agreement and the SNOMED CT® Canadian National License Agreement. To acknowledge and accept these agreements, register an account on Canada Health Infoway. For additional information on the agreements, please visit Canada Health Infoway.
- Version:
- 1.0.12